Genesis Therapeutics
Ken Leidal is an experienced Senior Machine Learning Research Engineer who has worked at Genesis Therapeutics, PathAI, Posh Technologies, and various other tech companies. Ken has a strong background in machine learning, AI research, and software engineering, with a focus on optimizing models and developing innovative techniques. Ken has made significant contributions to various projects and teams throughout their career, displaying expertise in neural architecture, NLP models, and software development. Additionally, Ken holds a Master of Engineering degree in Computer Science from the Massachusetts Institute of Technology.
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.